These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8856351)

  • 1. Immune responses to varicella-zoster virus.
    Arvin AM
    Infect Dis Clin North Am; 1996 Sep; 10(3):529-70. PubMed ID: 8856351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.
    Weinberg A; Lazar AA; Zerbe GO; Hayward AR; Chan IS; Vessey R; Silber JL; MacGregor RR; Chan K; Gershon AA; Levin MJ
    J Infect Dis; 2010 Apr; 201(7):1024-30. PubMed ID: 20170376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.
    Choi UY; Huh DH; Kim JH; Kang JH
    Hum Vaccin Immunother; 2016 Oct; 12(10):2560-2564. PubMed ID: 27484734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
    Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
    Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular studies of the Oka varicella vaccine.
    Quinlivan M; Breuer J; Schmid DS
    Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
    Speth F; Hinze CH; Andel S; Mertens T; Haas JP
    Pediatr Rheumatol Online J; 2018 Mar; 16(1):15. PubMed ID: 29499726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children.
    Krause PR; Klinman DM
    Nat Med; 2000 Apr; 6(4):451-4. PubMed ID: 10742154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
    Haberthur K; Engelmann F; Park B; Barron A; Legasse A; Dewane J; Fischer M; Kerns A; Brown M; Messaoudi I
    PLoS Pathog; 2011 Nov; 7(11):e1002367. PubMed ID: 22102814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine.
    Watson B; Gupta R; Randall T; Starr S
    J Infect Dis; 1994 Jan; 169(1):197-9. PubMed ID: 8277182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccinees.
    Krause PR
    Arch Virol Suppl; 2001; (17):7-15. PubMed ID: 11339552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interleukin-2 receptor, CD25, on CD4 lymphocytes in response to varicella-zoster virus antigen among patients with malignancies immunized with live attenuated varicella vaccine.
    Oitani K
    Pediatr Int; 1999 Feb; 41(1):32-6. PubMed ID: 10200133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
    Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
    J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
    Berger R; Trannoy E; Holländer G; Bailleux F; Rudin C; Creusvaux H
    J Infect Dis; 1998 Nov; 178 Suppl 1():S99-103. PubMed ID: 9852985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.